Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jun;35(6):1454–1459. doi: 10.1128/jcm.35.6.1454-1459.1997

Rapid identification of Candida species in blood cultures by a clinically useful PCR method.

J H Shin 1, F S Nolte 1, C J Morrison 1
PMCID: PMC229766  PMID: 9163461

Abstract

Widespread use of fluconazole for the prophylaxis and treatment of candidiasis has led to a reduction in the number of cases of candidemia caused by Candida albicans but has also resulted in the emergence of candidemias caused by innately fluconazole-resistant, non-C. albicans Candida species. Given the fulminant and rapidly fatal outcome of acute disseminated candidiasis, rapid identification of newly emerging Candida species in blood culture is critical for the implementation of appropriately targeted antifungal drug therapy. Therefore, we used a PCR-based assay to rapidly identify Candida species from positive blood culture bottles. This assay used fungus-specific, universal primers for DNA amplification and species-specific probes to identify C. albicans, C. krusei, C. parapsilosis, C. tropicalis, or C. glabrata amplicons. It also used a simpler and more rapid (1.5-h) sample preparation technique than those described previously and used detergent, heat, and mechanical breakage to recover Candida species DNA from blood cultures. A simple and rapid (3.5-h) enzyme immunosorbent assay (EIA)-based format was then used for amplicon detection. One hundred fifty blood culture bottles, including 73 positive blood culture bottle sets (aerobic and anaerobic) from 31 patients with candidemia, were tested. The combined PCR and EIA methods (PCR-EIA) correctly identified all Candida species in 73 blood culture bottle sets, including bottles containing bacteria coisolated with yeasts and 3 cultures of samples from patients with mixed candidemias originally identified as single-species infections by routine phenotypic identification methods. Species identification time was reduced from a mean of 3.5 days by routine phenotypic methods to 7 h by the PCR-EIA method. No false-positive results were obtained for patients with bacteremias (n = 18), artificially produced non-Candida fungemias (n = 3), or bottles with no growth (n = 20). Analytical sensitivity was 1 cell per 2-microl sample. This method is simpler and more rapid than previously described molecular identification methods, can identify all five of the most medically important Candida species, and has the potential to be automated for use in the clinical microbiology laboratory.

Full Text

The Full Text of this article is available as a PDF (140.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck-Sagué C., Jarvis W. R. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993 May;167(5):1247–1251. doi: 10.1093/infdis/167.5.1247. [DOI] [PubMed] [Google Scholar]
  2. Buchman T. G., Rossier M., Merz W. G., Charache P. Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery. 1990 Aug;108(2):338–347. [PubMed] [Google Scholar]
  3. Burgener-Kairuz P., Zuber J. P., Jaunin P., Buchman T. G., Bille J., Rossier M. Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment. J Clin Microbiol. 1994 Aug;32(8):1902–1907. doi: 10.1128/jcm.32.8.1902-1907.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dooley D. P., Beckius M. L., Jeffrey B. S. Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card. J Clin Microbiol. 1994 Dec;32(12):2889–2892. doi: 10.1128/jcm.32.12.2889-2892.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fraser V. J., Jones M., Dunkel J., Storfer S., Medoff G., Dunagan W. C. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis. 1992 Sep;15(3):414–421. doi: 10.1093/clind/15.3.414. [DOI] [PubMed] [Google Scholar]
  6. Fujita S., Lasker B. A., Lott T. J., Reiss E., Morrison C. J. Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol. 1995 Apr;33(4):962–967. doi: 10.1128/jcm.33.4.962-967.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holmes A. R., Lee Y. C., Cannon R. D., Jenkinson H. F., Shepherd M. G. Yeast-specific DNA probes and their application for the detection of Candida albicans. J Med Microbiol. 1992 Nov;37(5):346–351. doi: 10.1099/00222615-37-5-346. [DOI] [PubMed] [Google Scholar]
  8. Hopfer R. L., Walden P., Setterquist S., Highsmith W. E. Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis. J Med Vet Mycol. 1993;31(1):65–75. doi: 10.1080/02681219380000071. [DOI] [PubMed] [Google Scholar]
  9. Jarvis W. R. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995 Jun;20(6):1526–1530. doi: 10.1093/clinids/20.6.1526. [DOI] [PubMed] [Google Scholar]
  10. Jones J. M. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev. 1990 Jan;3(1):32–45. doi: 10.1128/cmr.3.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kan V. L. Polymerase chain reaction for the diagnosis of candidemia. J Infect Dis. 1993 Sep;168(3):779–783. doi: 10.1093/infdis/168.3.779. [DOI] [PubMed] [Google Scholar]
  12. Kwok S., Higuchi R. Avoiding false positives with PCR. Nature. 1989 May 18;339(6221):237–238. doi: 10.1038/339237a0. [DOI] [PubMed] [Google Scholar]
  13. Matthews R. C. Early diagnosis of systemic candidal infection. J Antimicrob Chemother. 1993 Jun;31(6):809–812. doi: 10.1093/jac/31.6.809. [DOI] [PubMed] [Google Scholar]
  14. Miyakawa Y., Mabuchi T., Fukazawa Y. New method for detection of Candida albicans in human blood by polymerase chain reaction. J Clin Microbiol. 1993 Dec;31(12):3344–3347. doi: 10.1128/jcm.31.12.3344-3347.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nguyen M. H., Peacock J. E., Jr, Morris A. J., Tanner D. C., Nguyen M. L., Snydman D. R., Wagener M. M., Rinaldi M. G., Yu V. L. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996 Jun;100(6):617–623. doi: 10.1016/s0002-9343(95)00010-0. [DOI] [PubMed] [Google Scholar]
  16. Odds F. C., Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994 Aug;32(8):1923–1929. doi: 10.1128/jcm.32.8.1923-1929.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Panaccio M., Lew A. PCR based diagnosis in the presence of 8% (v/v) blood. Nucleic Acids Res. 1991 Mar 11;19(5):1151–1151. doi: 10.1093/nar/19.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pfaller M. A. Epidemiology of candidiasis. J Hosp Infect. 1995 Jun;30 (Suppl):329–338. doi: 10.1016/0195-6701(95)90036-5. [DOI] [PubMed] [Google Scholar]
  19. Price M. F., LaRocco M. T., Gentry L. O. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother. 1994 Jun;38(6):1422–1424. doi: 10.1128/aac.38.6.1422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Reiss E., Morrison C. J. Nonculture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev. 1993 Oct;6(4):311–323. doi: 10.1128/cmr.6.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Wingard J. R. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis. 1995 Jan;20(1):115–125. doi: 10.1093/clinids/20.1.115. [DOI] [PubMed] [Google Scholar]
  22. Wingard J. R., Merz W. G., Rinaldi M. G., Johnson T. R., Karp J. E., Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991 Oct 31;325(18):1274–1277. doi: 10.1056/NEJM199110313251803. [DOI] [PubMed] [Google Scholar]
  23. van Deventer A. J., Goessens W. H., van Belkum A., van Vliet H. J., van Etten E. W., Verbrugh H. A. Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. J Clin Microbiol. 1995 Mar;33(3):625–628. doi: 10.1128/jcm.33.3.625-628.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES